Denmark · Biotechnology startup
Denmark · IO Biotech
IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.
Funding reportedLast round: Post ipo equity
Follow IO Biotech and see its new rounds in your feed.Start following
What company datasets say IO Biotech raised
Funding, as reported
Reported in all175Min the source's currency
Rounds5
Last roundPost ipo equity
Last round dateAug 2023
Investors listed16
Founders and team
From IO Biotech's own website: 2 on the team.
- Amy SullivanChief Financial Officer
- Devin SmithGeneral Counsel
On 4 portfolio pages
Investors who name them
Each firm lists IO Biotech on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in Denmark
Startups like it
Is this your company?
Add your raise, your deck and your story, and put IO Biotech in front of investors. Or tell us what we have wrong.